Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABG
Efficacy of Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in Coronary Artery Bypass Graft Surgery: A Randomized Double Blinded Study
1 other identifier
interventional
320
1 country
2
Brief Summary
Background: In cardiac surgery, myocardial protection is mandatory during cross clamp time followed by reperfusion. Use of cardioplegic solutions preserves myocardial energy stores, hindering electrolyte disturbances and acidosis during periods of myocardial ischemia. This study was designed to compare the efficacy and safety of Histidine-tryptophan-ketoglutarate (HTK) solution versus blood cardioplegia in coronary artery bypass graft surgery. Methods: Three hundred and twenty patients were randomized into Histidine-tryptophan-ketoglutarate (HTK) group and blood cardioplegia group. Ventilation time, total bypass time, cross clamp time, length of ICU or hospital stay and the early postoperative outcomes were analysed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Dec 2019
Shorter than P25 for early_phase_1
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2019
CompletedFirst Posted
Study publicly available on registry
December 18, 2019
CompletedStudy Start
First participant enrolled
December 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2020
CompletedMay 7, 2020
May 1, 2020
3 months
December 16, 2019
May 5, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
mortality rate
mortality rate
up to 30 days postoperative
Secondary Outcomes (3)
Troponin I level
Up to 24 hours postoperative
length of ICU stay
up to 3 days postoperative
length of hospital stay
up to 7 days postoperative
Study Arms (2)
HTK group
SHAM COMPARATORPatients received 30 ml/kg of HTK cardioplegic solution at 4°C through an antegrade fashion at an initial perfusion pressure of 80-100 mmHg
blood cardioplegia group
ACTIVE COMPARATORpatients received one liter of blood cardioplegia was given with the antegrade route at 30°C, or lower. Blood maintenance cardioplegia was repeated every 30-45mins
Interventions
30 ml/kg of HTK cardioplegic solution at 4°C through an antegrade fashion at an initial perfusion pressure of 80-100 mmHg
one liter of blood cardioplegia was given with the antegrade route at 30°C, or lower. Blood maintenance cardioplegia was repeated every 30-45mins
Eligibility Criteria
You may qualify if:
- age from 60-80 years old
- elective CABG
- no comorbidities
You may not qualify if:
- patients with Unstable angina
- Poor left ventricular function
- Patient with acute myocardial infarction
- previous renal failure
- Preoperative Aortic valve or Mitral valve disease requiring replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ain Shams university
Cairo, 11566, Egypt
Ain Shams university
Cairo, Egypt
MeSH Terms
Interventions
Study Officials
- STUDY CHAIR
Ayman shoeb
Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of Anaesthesiology
Study Record Dates
First Submitted
December 16, 2019
First Posted
December 18, 2019
Study Start
December 25, 2019
Primary Completion
March 31, 2020
Study Completion
April 25, 2020
Last Updated
May 7, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 4 months
- Access Criteria
- Data were analyzed using SPSS Statistics version 23 (IBM© Corp., Armonk, NY, USA). Normally distributed numerical data were presented as mean and SD, and skewed data were presented as median and interquartile range. Qualitative data were presented as number and percentage or ratio. Normally distributed numerical data were compared using the unpaired t-test. Skewed numerical data were compared using the Mann-Whitney test and categorical data were compared using Fisher's exact test. P-value \< 0.05 were considered statistically significant.
study protocol